Pharma Equity Group A/S
PEG.CO · CPH
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -1.68 | 0.70 |
| FCF Yield | 0.00% | -3.43% | -1.89% | -1.26% |
| EV / EBITDA | 0.00 | -48.30 | -56.14 | -71.94 |
| Quality | ||||
| ROIC | 0.00% | -6.50% | -6.89% | -6.69% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.32 | 0.63 | 0.66 | 1.01 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | -47.88% | -16.33% | 50.55% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -2.25 | -9.56 | -8.84 |
| Interest Coverage | 0.00 | -5.16 | -2.75 | -3.91 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -4,265.56 | -3,340.89 |